PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

BioRem Inc.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

BioRem Inc. owes C$0.51 for every C$1 it owns. Net profit rose 58% in the year to Dec 2025, and grew 44% a year on average over 3 years.

Compared with Industrials companies in Canada · latest annual results Dec 2025.

P/E ratio

11.5

Investors pay C$11.5 for every C$1 of BioRem Inc.'s yearly profit, lower than 85% of Industrials companies in Canada.

P/B ratio

3.50

The share price is 3.50 times BioRem Inc.'s book value per share, higher than 58% of Industrials companies in Canada.

Market cap

C$62 M

The total market value of all of BioRem Inc.'s shares at today's price (share price × number of shares), smaller than 54% of Industrials companies in Canada. PosiCap size class: Micro Cap.

Net worth (book value)

C$18 M

What BioRem Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

C$1.09

Net worth divided by the number of shares. The share price of C$3.80 is 3.5 times this, which is the P/B above.

Return on equity (ROE)

43.6%

BioRem Inc. earned 43.6% on its shareholders' money over the last year, higher than 97% of Industrials companies in Canada.

Owes vs Owns

0.51×

BioRem Inc. owes C$0.51 for every C$1 it owns (moderate), lower than 64% of Industrials companies in Canada.

Dividend yield

None

BioRem Inc. does not currently pay a dividend.

Revenue growth

+13%

Revenue rose 13% in the year to Dec 2025, and grew 14% a year on average over 3 years.

Profit growth

+58%

Net profit rose 58% in the year to Dec 2025, and grew 44% a year on average over 3 years.

Profit margin

11.4%

BioRem Inc. keeps C$11 of every C$100 of revenue as net profit.

Cash quality

1.6×

Cash from BioRem Inc.'s business was 1.6× its reported profit in the year to Dec 2025 — its profit turned into cash.

Interest cover

40.6×

BioRem Inc.'s operating profit covered its interest costs 40.6 times in the year to Dec 2025.

Cash vs debt

Net cash

BioRem Inc. held C$9 M more cash than debt (net cash) at Dec 2025.

Questions

What is BioRem Inc.'s P/E ratio?

Investors pay C$11.5 for every C$1 of BioRem Inc.'s yearly profit, lower than 85% of Industrials companies in Canada.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For BioRem Inc.: C$62 M ÷ C$18 M (30 Jun 2026) = 3.5.

What is BioRem Inc.'s return on equity?

BioRem Inc. earned 43.6% on its shareholders' money over the last year, higher than 97% of Industrials companies in Canada.

How much does BioRem Inc. owe compared with what it owns?

BioRem Inc. owes C$0.51 for every C$1 it owns (moderate), lower than 64% of Industrials companies in Canada.

Does BioRem Inc. pay a dividend?

No. BioRem Inc. does not currently pay a dividend.

Is BioRem Inc.'s revenue growing?

Revenue rose 13% in the year to Dec 2025, and grew 14% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.